Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

179.71 +0.29 (+0.16%)
Streaming Delayed Price Updated: 2:21 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
NATERA INC is setting up nicely for a breakout.
Exploring NATERA INC's Technical Signals and Breakout Potential: A technical analysis of NATERA INC (NASDAQ:NTRA) shows it may be setting up for a breakout. 
Via Chartmill
Why NATERA INC (NASDAQ:NTRA) qualifies as a high growth stock.
Should you consider NATERA INC (NASDAQ:NTRA) for high growth investing? A fundamental and technical analysis of (NASDAQ:NTRA). 
Via Chartmill
The S&P 500 Fights Through Challenging Headlines To Close At New Weekly All-Time Highs
In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha. 
Via Talk Markets
Topics Stocks Stocks / Equities
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
From Natera, Inc.
Via Business Wire
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Exploring high growth characteristics of NATERA INC (NASDAQ:NTRA). A fundamental and technical analysis of (NASDAQ:NTRA). 
Via Chartmill
Looking Into Natera's Recent Short Interest
 
Via Benzinga
Natera Announces National Commercial Coverage for its Fetal RhD NIPT
From Natera, Inc.
Via Business Wire
Small- To Mid-Cap Biotech Trades Poised For Gains
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these... 
Via Talk Markets
Topics ETFs Stocks / Equities
Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer
From Natera, Inc.
Via Business Wire
Natera to Present New Data at the 2025 ASCO GI Symposium
From Natera, Inc.
Via Business Wire
The Analyst Verdict: Natera In The Eyes Of 14 Experts
 
Via Benzinga
Why NASDAQ:NTRA qualifies as a high growth stock.
Should you consider NATERA INC (NASDAQ:NTRA) for high growth investing? 
Via Chartmill
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
The company is working to expand the uses and reimbursement for its blood-based tests for cancer. 
Via Investor's Business Daily
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,... 
Via Benzinga
The End Of The 60/40 Portfolio
Since bonds don't protect against stock declines, it's time for a different approach. 
Via Benzinga
Topics Bonds
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
Exploring NASDAQ:NTRA's high growth characteristics.
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA). 
Via Chartmill
Looking Into Natera's Recent Short Interest
 
Via Benzinga
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year
From Natera, Inc.
Via Business Wire
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection
From Natera, Inc.
Via Business Wire
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024
From Natera, Inc.
Via Business Wire
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Via The Motley Fool
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Natera, Inc.
Via Business Wire
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next
Druckenmiller's Duquesne Family Office sold Nvidia and Palantir stocks while increasing stake in Teva Pharmaceutical, signaling a shift in investment focus. 
Via Benzinga
Topics Artificial Intelligence
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Via The Motley Fool
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252%
Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million. 
Via Benzinga
Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
From Natera, Inc.
Via Business Wire
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
From Natera, Inc.
Via Business Wire
Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment
From Natera, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.